Ignite Creation Date:
2024-05-05 @ 11:24 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01328249
Status:
COMPLETED
Last Update Posted:
2019-08-20
First Post:
2011-03-22
Brief Title:
Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer
Sponsor:
Eisai Inc
Organization:
Eisai Inc